Xtant Medical Holdings, Inc.
AMEX:XTNT
1.15 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 91.303 | 57.969 | 55.263 | 53.337 | 64.682 | 72.203 | 82.612 | 90.003 | 59.346 | 35.332 | 33.073 | 32.98 | 30.149 | 15.418 | 7.393 | 0.459 |
| Cost of Revenue
| 35.836 | 25.832 | 22.773 | 18.945 | 22.166 | 28.717 | 32.511 | 27.71 | 20.263 | 13.034 | 14.186 | 10.337 | 9.109 | 3.364 | 2.318 | 0.386 |
| Gross Profit
| 55.467 | 32.137 | 32.49 | 34.392 | 42.516 | 43.486 | 50.101 | 62.293 | 39.083 | 22.297 | 18.888 | 22.643 | 21.04 | 12.054 | 5.075 | 0.073 |
| Gross Profit Ratio
| 0.608 | 0.554 | 0.588 | 0.645 | 0.657 | 0.602 | 0.606 | 0.692 | 0.659 | 0.631 | 0.571 | 0.687 | 0.698 | 0.782 | 0.686 | 0.158 |
| Reseach & Development Expenses
| 1.336 | 0.915 | 0.87 | 0.657 | 0.932 | 1.702 | 2.441 | 3.411 | 2.546 | 1.443 | 0.572 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 25.85 | 15.462 | 14.449 | 13.503 | 17.936 | 13.001 | 15.331 | 16.029 | 13.239 | 9.022 | 10.772 | 11.563 | 8.234 | 11.137 | 0 | 0 |
| Selling & Marketing Expenses
| 38.439 | 22.515 | 21.025 | 20.983 | 25.843 | 32.059 | 40.511 | 44.056 | 28.731 | 16.913 | 16.017 | 15.617 | 18.501 | 8.897 | 0 | 0 |
| SG&A
| 64.289 | 37.977 | 35.474 | 34.486 | 43.779 | 45.06 | 55.842 | 60.085 | 41.971 | 25.935 | 26.789 | 27.18 | 26.735 | 20.034 | 4.162 | 0.089 |
| Other Expenses
| -0.049 | 0 | 0 | 0 | 0.058 | 0.003 | -0.075 | -0.352 | 0.388 | -0.319 | 0.093 | -1.559 | 0.755 | 0.634 | 0.072 | 0.089 |
| Operating Expenses
| 65.625 | 38.892 | 36.344 | 35.143 | 44.769 | 50.88 | 63.768 | 68.437 | 48.337 | 27.65 | 27.167 | 27.587 | 27.491 | 20.668 | 8.698 | 0.089 |
| Operating Income
| -10.158 | -6.755 | -3.854 | -0.751 | -2.354 | -60.078 | -37.834 | -7.545 | -12.078 | -6.265 | -9.008 | -4.945 | -6.45 | -8.614 | -3.623 | -0.016 |
| Operating Income Ratio
| -0.111 | -0.117 | -0.07 | -0.014 | -0.036 | -0.832 | -0.458 | -0.084 | -0.204 | -0.177 | -0.272 | -0.15 | -0.214 | -0.559 | -0.49 | -0.035 |
| Total Other Income Expenses Net
| 9.121 | -1.661 | -0.995 | -5.976 | -5.769 | -52.56 | -24.039 | -1.037 | -2.724 | 0.505 | 0.239 | -0.198 | 4.607 | -9.207 | 0.011 | 0 |
| Income Before Tax
| -1.037 | -8.416 | -4.849 | -6.727 | -8.123 | -70.099 | -52.411 | -19.443 | -19.712 | -10.508 | -12.693 | -7.714 | -3.006 | -19.468 | -4.126 | -0.016 |
| Income Before Tax Ratio
| -0.011 | -0.145 | -0.088 | -0.126 | -0.126 | -0.971 | -0.634 | -0.216 | -0.332 | -0.297 | -0.384 | -0.234 | -0.1 | -1.263 | -0.558 | -0.035 |
| Income Tax Expense
| -1.697 | 0.069 | 0.995 | 0.296 | 0.098 | 0.124 | 14.63 | 0.05 | -17.537 | 5.342 | 4.746 | 0.306 | 1.163 | 1.648 | 0.002 | 0 |
| Net Income
| 0.66 | -8.485 | -5.844 | -7.023 | -8.221 | -70.099 | -52.411 | -19.494 | -2.174 | -10.508 | -12.693 | -7.714 | -3.006 | -19.468 | -4.126 | -0.016 |
| Net Income Ratio
| 0.007 | -0.146 | -0.106 | -0.132 | -0.127 | -0.971 | -0.634 | -0.217 | -0.037 | -0.297 | -0.384 | -0.234 | -0.1 | -1.263 | -0.558 | -0.035 |
| EPS
| 0.006 | -0.09 | -0.068 | -0.25 | -0.62 | -5.97 | -34.76 | -18.46 | -2.62 | -19.26 | -29.15 | -19.83 | -8.43 | -66.03 | -17.02 | -0.065 |
| EPS Diluted
| 0.005 | -0.09 | -0.068 | -0.25 | -0.62 | -5.93 | -34.51 | -18.32 | -2.62 | -19.26 | -29.15 | -19.83 | -8.43 | -66.03 | -17.02 | -0.065 |
| EBITDA
| -6.984 | -5.432 | -2.522 | 1.328 | 0.789 | -0.801 | -5.334 | 0.746 | -3.976 | -4.719 | -7.809 | -6.426 | -5.695 | -7.931 | -2.904 | -0.016 |
| EBITDA Ratio
| -0.076 | -0.094 | -0.046 | 0.025 | 0.012 | -0.011 | -0.065 | 0.008 | -0.067 | -0.134 | -0.236 | -0.195 | -0.189 | -0.514 | -0.393 | -0.035 |